https://www.sciencedaily.com/news/health_medicine/cancer/ Read the latest medical research on risk factors for cancer, cancer symptoms, treatments and more. Updated daily. en-us Tue, 21 Apr 2026 11:02:48 EDT Tue, 21 Apr 2026 11:02:48 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/cancer/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260420014746.htm A key protein, HOXD13, helps melanoma tumors grow and evade the immune system by boosting blood supply and blocking cancer-fighting T cells. Disabling it shrinks tumors and reopens the door for the immune system—offering a new path for treatment. Tue, 21 Apr 2026 03:40:31 EDT https://www.sciencedaily.com/releases/2026/04/260420014746.htm https://www.sciencedaily.com/releases/2026/04/260420014744.htm Cancer cells are known for their “glutamine addiction,” but many can escape this weakness by switching to alternative fuels. Researchers found that vitamin B7 acts like a metabolic “license,” enabling this escape route through a key enzyme. Without biotin, cancer cells lose that flexibility and stop growing. Mutations in a cancer-linked gene can make this vulnerability even stronger, offering a promising new target for therapy. Mon, 20 Apr 2026 07:14:27 EDT https://www.sciencedaily.com/releases/2026/04/260420014744.htm https://www.sciencedaily.com/releases/2026/04/260417224454.htm A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be linked to a higher risk of lung cancer in younger non-smokers. Researchers found that patients under 50 diagnosed with lung cancer often had better-than-average diets, raising the possibility that pesticide exposure from conventionally grown produce could be a hidden culprit. Fri, 17 Apr 2026 23:27:27 EDT https://www.sciencedaily.com/releases/2026/04/260417224454.htm https://www.sciencedaily.com/releases/2026/04/260414075650.htm Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer and chronic disease. By using mice engineered with human antibody genes, researchers created powerful human-like antibodies that block the virus from attaching to and entering immune cells. One of these antibodies completely prevented infection in lab models with human immune systems, marking a breakthrough after years of difficulty tackling EBV’s ability to invade nearly all B cells. Wed, 15 Apr 2026 03:26:50 EDT https://www.sciencedaily.com/releases/2026/04/260414075650.htm https://www.sciencedaily.com/releases/2026/04/260411022031.htm Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease progression remains a major hurdle. By studying how tumors interact with and suppress the immune system, scientists aim to identify new biomarkers that reveal how the cancer evolves. Using real patient samples, the team hopes to turn earlier discoveries into practical clinical tools. The goal: more precise, personalized treatments that can outsmart even the most dangerous tumors. Sun, 12 Apr 2026 07:03:28 EDT https://www.sciencedaily.com/releases/2026/04/260411022031.htm https://www.sciencedaily.com/releases/2026/04/260411022029.htm A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly. Sun, 12 Apr 2026 08:58:54 EDT https://www.sciencedaily.com/releases/2026/04/260411022029.htm https://www.sciencedaily.com/releases/2026/04/260411022027.htm A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines. Sun, 12 Apr 2026 06:42:12 EDT https://www.sciencedaily.com/releases/2026/04/260411022027.htm https://www.sciencedaily.com/releases/2026/04/260410083114.htm A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found in everyday vegetables and supplements, it’s safe, accessible, and shows strong potential as a cancer therapy booster. Human trials are the next step. Fri, 10 Apr 2026 09:55:45 EDT https://www.sciencedaily.com/releases/2026/04/260410083114.htm https://www.sciencedaily.com/releases/2026/04/260409101106.htm Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective. Fri, 10 Apr 2026 22:31:35 EDT https://www.sciencedaily.com/releases/2026/04/260409101106.htm https://www.sciencedaily.com/releases/2026/04/260409101055.htm Cancer drugs known as BET inhibitors once looked like a breakthrough, but in real patients they’ve often fallen short. New research reveals a key reason why: two closely related proteins, BRD2 and BRD4, don’t actually do the same job. Instead, BRD2 acts like a “stage manager,” preparing genes for activation, while BRD4 triggers the final step that turns them on. By blocking both at once, current drugs may be disrupting the process in unpredictable ways. Thu, 09 Apr 2026 23:42:35 EDT https://www.sciencedaily.com/releases/2026/04/260409101055.htm https://www.sciencedaily.com/releases/2026/04/260407073850.htm Vitamin D levels in midlife may play a bigger role in long-term brain health than previously thought. In a study following nearly 800 people over 16 years, those with higher vitamin D levels in their 30s and 40s had lower levels of tau protein later on, a key marker linked to dementia. Tue, 07 Apr 2026 07:47:09 EDT https://www.sciencedaily.com/releases/2026/04/260407073850.htm https://www.sciencedaily.com/releases/2026/04/260406080131.htm Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone density in mice and counteract osteoporosis-like damage. The finding opens the door to a new kind of treatment that could not only prevent bone loss but also rebuild weakened bones, offering fresh hope for millions affected by osteoporosis, especially aging populations. Mon, 06 Apr 2026 08:14:33 EDT https://www.sciencedaily.com/releases/2026/04/260406080131.htm https://www.sciencedaily.com/releases/2026/04/260405003949.htm Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of thousands of deaths each year. The drug bemnifosbuvir, currently in trials for hepatitis C, was found to block the virus from replicating by disrupting its genetic machinery. Tests in cells and animals showed strong effectiveness without harming healthy tissue. If ongoing trials succeed, the drug could soon be repurposed for hepatitis E. Mon, 06 Apr 2026 05:00:20 EDT https://www.sciencedaily.com/releases/2026/04/260405003949.htm https://www.sciencedaily.com/releases/2026/04/260405003933.htm Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can actually help tumors grow by sending signals that strengthen cancer cells. When researchers blocked this communication, tumor growth slowed dramatically in lab models. Sun, 05 Apr 2026 19:48:12 EDT https://www.sciencedaily.com/releases/2026/04/260405003933.htm https://www.sciencedaily.com/releases/2026/04/260401071951.htm Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, researchers discovered that only colorectal tumors consistently host distinct microbial communities—challenging the long-held belief that all cancers have their own microbial signatures. Wed, 01 Apr 2026 23:54:49 EDT https://www.sciencedaily.com/releases/2026/04/260401071951.htm https://www.sciencedaily.com/releases/2026/03/260330001131.htm A large U.S. study reveals that more than a quarter of people with hard-to-treat high blood pressure may have an overlooked hormone problem. Elevated cortisol—often linked to stress—was found in 27% of these patients, far higher than expected. This hidden condition could explain why standard medications fail. The discovery could lead to new testing and treatments that finally help bring blood pressure under control. Mon, 30 Mar 2026 03:50:56 EDT https://www.sciencedaily.com/releases/2026/03/260330001131.htm https://www.sciencedaily.com/releases/2026/03/260330001129.htm A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically used for people who already have cardiovascular disease, can significantly cut the risk of first-time heart attacks and strokes in high-risk patients with diabetes—even before any artery-clogging plaque is detected. Mon, 30 Mar 2026 03:29:23 EDT https://www.sciencedaily.com/releases/2026/03/260330001129.htm https://www.sciencedaily.com/releases/2026/03/260328043554.htm A major new U.S. cholesterol guideline is shifting the focus toward earlier, more personalized prevention of heart disease. It urges people to start screening sooner—sometimes even in childhood—and highlights the importance of tracking not just LDL (“bad”) cholesterol but also genetic risk factors like lipoprotein(a). A new, more advanced risk calculator now uses broader health data to better predict heart attack and stroke risk over decades. Sun, 29 Mar 2026 05:43:08 EDT https://www.sciencedaily.com/releases/2026/03/260328043554.htm https://www.sciencedaily.com/releases/2026/03/260326075550.htm Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release reservoirs that create uneven drug distribution. This means some cancer cells are heavily exposed while others are barely affected. Understanding this process could help doctors better tailor treatments and improve outcomes. Fri, 27 Mar 2026 08:31:17 EDT https://www.sciencedaily.com/releases/2026/03/260326075550.htm https://www.sciencedaily.com/releases/2026/03/260325005917.htm Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps tumors grow and spread. Even more surprising, it pushes cancer cells into a more aggressive, neuron-like state linked to relapse. Wed, 25 Mar 2026 07:52:39 EDT https://www.sciencedaily.com/releases/2026/03/260325005917.htm https://www.sciencedaily.com/releases/2026/03/260324080203.htm Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available vitamin could become a powerful new treatment. Tue, 24 Mar 2026 08:09:15 EDT https://www.sciencedaily.com/releases/2026/03/260324080203.htm https://www.sciencedaily.com/releases/2026/03/260323005543.htm Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide lost about 35% more weight than those on the drug alone. The findings hint at a surprising synergy between hormones and cutting-edge weight-loss medications, potentially opening the door to more effective, personalized treatments for millions of women facing increased cardiometabolic risks after menopause. Mon, 23 Mar 2026 21:06:37 EDT https://www.sciencedaily.com/releases/2026/03/260323005543.htm https://www.sciencedaily.com/releases/2026/03/260323005540.htm A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the blood that, when combined with existing markers, dramatically improved detection accuracy. The four-marker test was able to spot pancreatic cancer in over 90% of cases and performed especially well even in early stages, when treatment has the best chance of success. Mon, 23 Mar 2026 03:33:52 EDT https://www.sciencedaily.com/releases/2026/03/260323005540.htm https://www.sciencedaily.com/releases/2026/03/260321012709.htm Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon tumor cells, they identified gene patterns that signal whether a cancer is likely to metastasize. Their AI model, MangroveGS, can predict this risk with about 80% accuracy and even works across multiple cancer types. This could transform how doctors decide who needs aggressive treatment and who doesn’t. Sat, 21 Mar 2026 07:44:32 EDT https://www.sciencedaily.com/releases/2026/03/260321012709.htm https://www.sciencedaily.com/releases/2026/03/260321012659.htm A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome one of the biggest barriers keeping patients from using current treatments. Researchers say many people still don’t reach safe cholesterol levels—even on statins—highlighting the need for better options. Sat, 21 Mar 2026 08:04:04 EDT https://www.sciencedaily.com/releases/2026/03/260321012659.htm https://www.sciencedaily.com/releases/2026/03/260319044719.htm A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it causes DNA damage and speeds tumor growth and spread. It also appears to make cancer cells more aggressive and resistant to therapy. The effect is even stronger in people with BRCA1 mutations, raising new questions about the role of oral health in cancer risk. Thu, 19 Mar 2026 23:37:17 EDT https://www.sciencedaily.com/releases/2026/03/260319044719.htm https://www.sciencedaily.com/releases/2026/03/260319044708.htm Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and summon immune fighters deep into the tumor. These immune cells persist and attack, which was linked to longer survival in patients. Fri, 20 Mar 2026 07:59:34 EDT https://www.sciencedaily.com/releases/2026/03/260319044708.htm https://www.sciencedaily.com/releases/2026/03/260319044659.htm A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications that can lead to heart attacks and strokes. The effect is so strong, it rivals the benefits of quitting smoking. Fri, 20 Mar 2026 08:10:25 EDT https://www.sciencedaily.com/releases/2026/03/260319044659.htm https://www.sciencedaily.com/releases/2026/03/260318033143.htm Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human cancers. Key mutations—like those linked to breast cancer—appear in both species, and some human cancer drugs may also work in cats. Because pets share our environments, these similarities could reveal shared causes of cancer. The research could lead to new treatments that benefit both animals and humans. Wed, 18 Mar 2026 19:12:17 EDT https://www.sciencedaily.com/releases/2026/03/260318033143.htm https://www.sciencedaily.com/releases/2026/03/260317015933.htm mRNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA nanostructures to better control how the immune system responds. In early studies, it produced strong antibody and T cell responses in both mice and human models. Researchers say it could lead to more stable, easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola. Tue, 17 Mar 2026 01:59:33 EDT https://www.sciencedaily.com/releases/2026/03/260317015933.htm https://www.sciencedaily.com/releases/2026/03/260315225121.htm A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission. Mon, 16 Mar 2026 20:18:42 EDT https://www.sciencedaily.com/releases/2026/03/260315225121.htm https://www.sciencedaily.com/releases/2026/03/260315001845.htm A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin D3 did not make COVID-19 infections less severe or reduce hospital visits. However, the study uncovered a subtle but intriguing signal suggesting that people who consistently took vitamin D supplements might be slightly less likely to develop long COVID symptoms weeks after infection. Sun, 15 Mar 2026 05:54:54 EDT https://www.sciencedaily.com/releases/2026/03/260315001845.htm https://www.sciencedaily.com/releases/2026/03/260313055130.htm A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumors develop months or years later. The increased risk was seen mainly after severe infections that required hospitalization. Vaccination, however, appears to prevent the dangerous lung changes. Fri, 13 Mar 2026 05:56:17 EDT https://www.sciencedaily.com/releases/2026/03/260313055130.htm https://www.sciencedaily.com/releases/2026/03/260311213453.htm Scientists have discovered that a rare “mirror-image” version of the amino acid cysteine can dramatically slow the growth of certain cancers while leaving healthy cells largely untouched. Unlike most anticancer treatments that harm normal tissues, this molecule—called D-cysteine—is taken up mainly by some cancer cells through a specific transporter on their surface. Once inside, it shuts down a crucial mitochondrial enzyme that cancer cells rely on to produce energy and maintain DNA, effectively halting their growth. Thu, 12 Mar 2026 18:48:39 EDT https://www.sciencedaily.com/releases/2026/03/260311213453.htm https://www.sciencedaily.com/releases/2026/03/260311004833.htm Coenzyme A, a molecule derived from vitamin B5, is vital for metabolism throughout the body. Scientists discovered that most of it resides inside mitochondria, yet how it reached these cellular powerhouses was unclear. Yale researchers have now identified the transport system that moves CoA into mitochondria, solving a long-standing biological puzzle. The discovery could help researchers better understand diseases linked to metabolic dysfunction and mitochondrial problems. Wed, 11 Mar 2026 18:32:18 EDT https://www.sciencedaily.com/releases/2026/03/260311004833.htm https://www.sciencedaily.com/releases/2026/03/260309225152.htm Cancer often begins when the genetic instructions that guide our cells become scrambled, allowing cells to grow uncontrollably. Now, scientists at EMBL have developed an AI-powered system called MAGIC that can automatically spot and tag cells showing early signs of chromosomal trouble—tiny DNA-filled structures known as micronuclei that are linked to future cancer development. Tue, 10 Mar 2026 19:12:39 EDT https://www.sciencedaily.com/releases/2026/03/260309225152.htm https://www.sciencedaily.com/releases/2026/03/260309225146.htm Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease. The compound, called SU212, targets and disables a key enzyme that cancer cells rely on to fuel their growth. In tests using humanized mouse models, the molecule caused tumors to shrink and slowed the spread of cancer by forcing the enzyme to break down. Tue, 10 Mar 2026 18:10:14 EDT https://www.sciencedaily.com/releases/2026/03/260309225146.htm https://www.sciencedaily.com/releases/2026/03/260309183010.htm Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic fingerprint.” Some of the enzymes gather around damaged DNA to assist with repair. The discovery reveals an unexpected link between metabolism and gene regulation that could influence how cancers grow and respond to treatment. Mon, 09 Mar 2026 19:54:17 EDT https://www.sciencedaily.com/releases/2026/03/260309183010.htm https://www.sciencedaily.com/releases/2026/03/260305223204.htm Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wide DNA fragmentation patterns rather than specific mutations, the approach captures hidden signals about a person’s overall health. Early detection could help doctors treat liver disease sooner and potentially prevent cancer. Fri, 06 Mar 2026 00:20:31 EST https://www.sciencedaily.com/releases/2026/03/260305223204.htm https://www.sciencedaily.com/releases/2026/03/260304184235.htm Scientists have uncovered new genetic rules that determine whether the immune system’s “killer” T cells remain powerful long-term defenders or become worn out and ineffective. By building a detailed genetic atlas of CD8 T cell states, researchers identified key molecular switches that push these cells toward either resilience or exhaustion. Remarkably, disabling just two previously unknown genes restored the tumor-killing power of exhausted T cells while preserving their ability to provide lasting immune protection. Thu, 05 Mar 2026 22:19:10 EST https://www.sciencedaily.com/releases/2026/03/260304184235.htm https://www.sciencedaily.com/releases/2026/03/260303050624.htm Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more structured and treatable form—but it gets shut down by an overactive KRAS-driven pathway. When researchers blocked that pathway, GATA6 levels rebounded and cancer cells became more sensitive to chemo. The discovery could help turn some of the toughest pancreatic tumours into ones doctors can better control. Tue, 03 Mar 2026 11:33:04 EST https://www.sciencedaily.com/releases/2026/03/260303050624.htm https://www.sciencedaily.com/releases/2026/03/260302030657.htm Polyamines—natural molecules found in every living cell—have become stars in the longevity world for their ability to boost cellular cleanup and support healthy aging. But there’s a dark twist: high levels of these same molecules are consistently seen in cancer, where tumors grow aggressively. Mon, 02 Mar 2026 06:13:04 EST https://www.sciencedaily.com/releases/2026/03/260302030657.htm https://www.sciencedaily.com/releases/2026/02/260228093456.htm Scientists at Oregon State University have engineered a powerful new nanomaterial that zeroes in on cancer cells and destroys them from the inside out. Designed to exploit cancer’s unique chemistry—its acidity and high hydrogen peroxide levels—the tiny iron-based structure sparks not one but two intense chemical reactions, flooding tumors with cell-damaging oxygen molecules. This dual attack overwhelms cancer cells with oxidative stress while sparing healthy tissue. Sun, 01 Mar 2026 09:09:30 EST https://www.sciencedaily.com/releases/2026/02/260228093456.htm https://www.sciencedaily.com/releases/2026/02/260225081214.htm Avoiding meat might slightly lower the odds of reaching 100 — but only for frail, underweight seniors. In very old age, staying strong and maintaining muscle matters more than long-term disease prevention. Older adults who included fish, eggs, or dairy were just as likely to become centenarians as meat eaters, suggesting that key nutrients may make the difference. The takeaway: nutrition needs change dramatically with age. Thu, 26 Feb 2026 03:57:06 EST https://www.sciencedaily.com/releases/2026/02/260225081214.htm https://www.sciencedaily.com/releases/2026/02/260225081153.htm A shingles shot might do more than prevent a painful rash — it could actually help slow down the aging process. In a large national study of more than 3,800 Americans age 70 and older, those who received the shingles vaccine showed slower biological aging compared to those who didn’t. Researchers found lower levels of chronic inflammation and slower changes in gene activity linked to aging, suggesting the vaccine may calm the body’s “inflammaging” — the low-grade inflammation tied to heart disease, frailty, and cognitive decline. Thu, 26 Feb 2026 02:47:45 EST https://www.sciencedaily.com/releases/2026/02/260225081153.htm https://www.sciencedaily.com/releases/2026/02/260225081150.htm Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as “Brain on Fire.” The disease strikes when the immune system attacks NMDA receptors—key molecules involved in memory and thinking—leading to psychiatric symptoms, seizures, and even death. Wed, 25 Feb 2026 11:08:42 EST https://www.sciencedaily.com/releases/2026/02/260225081150.htm https://www.sciencedaily.com/releases/2026/02/260225001250.htm Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue. Scientists say this is the first Western study to directly measure plastic particles in prostate tumors. More research is needed, but the findings suggest microplastic exposure could play a role in cancer development. Wed, 25 Feb 2026 01:28:19 EST https://www.sciencedaily.com/releases/2026/02/260225001250.htm https://www.sciencedaily.com/releases/2026/02/260222092258.htm Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels, prevented severe illness, and even blocked allergic reactions. Mon, 23 Feb 2026 08:45:18 EST https://www.sciencedaily.com/releases/2026/02/260222092258.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260216084527.htm A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across dozens of tumor types. These molecules form unique molecular signatures that identify cancer type and subtype with remarkable accuracy. Some even drive tumor growth and metastasis. Because many are released into the bloodstream, a simple blood test can track how patients respond to treatment and predict survival. Tue, 17 Feb 2026 03:50:37 EST https://www.sciencedaily.com/releases/2026/02/260216084527.htm https://www.sciencedaily.com/releases/2026/02/260216044006.htm Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune system’s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components. Wed, 18 Feb 2026 10:00:32 EST https://www.sciencedaily.com/releases/2026/02/260216044006.htm https://www.sciencedaily.com/releases/2026/02/260215225600.htm Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than trying to modify mature natural killer (NK) cells—they created a streamlined process that generates enormous numbers of highly potent NK cells, including CAR-equipped versions designed to hunt specific cancers. Tue, 17 Feb 2026 22:31:13 EST https://www.sciencedaily.com/releases/2026/02/260215225600.htm https://www.sciencedaily.com/releases/2026/02/260215225546.htm Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular structures, unleashing a burst of genetic changes that can help tumors rapidly adapt and resist therapy. Blocking the enzyme dramatically reduced this genomic destruction in cancer cells. Mon, 16 Feb 2026 01:00:42 EST https://www.sciencedaily.com/releases/2026/02/260215225546.htm https://www.sciencedaily.com/releases/2026/02/260215085001.htm Researchers tracked more than 400 toddlers to see whether mRNA COVID-19 vaccination during or just before pregnancy was linked to autism or developmental delays. After detailed assessments of speech, motor skills, behavior, and social development, they found no meaningful differences between vaccinated and unvaccinated groups. Experts say the results provide strong reassurance about vaccine safety in pregnancy. Sun, 15 Feb 2026 09:51:05 EST https://www.sciencedaily.com/releases/2026/02/260215085001.htm https://www.sciencedaily.com/releases/2026/02/260212025550.htm A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many other symptoms appeared just as often in people taking a placebo. Only a few side effects showed any link to statins — and even those were rare. Sun, 15 Feb 2026 00:35:50 EST https://www.sciencedaily.com/releases/2026/02/260212025550.htm https://www.sciencedaily.com/releases/2026/02/260211204208.htm Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve fibers, which then release signals that accelerate early cancer growth. This creates a self-sustaining loop that helps tumors take hold. Blocking the nerve activity significantly reduced tumor growth in experiments, suggesting a new treatment strategy. Sun, 15 Feb 2026 08:43:27 EST https://www.sciencedaily.com/releases/2026/02/260211204208.htm https://www.sciencedaily.com/releases/2026/02/260211073033.htm Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common. Wed, 11 Feb 2026 10:01:13 EST https://www.sciencedaily.com/releases/2026/02/260211073033.htm https://www.sciencedaily.com/releases/2026/02/260210040604.htm Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against infection—can be reprogrammed inside tumors to fuel cancer growth instead. Once exposed to the tumor environment, these immune cells begin producing a molecule called CCL3 that actively promotes tumor progression. Tue, 10 Feb 2026 10:28:42 EST https://www.sciencedaily.com/releases/2026/02/260210040604.htm https://www.sciencedaily.com/releases/2026/02/260210040559.htm Human evolution has long been tied to growing brain size, and new research suggests prenatal hormones may have played a surprising role. By studying the relative lengths of index and ring fingers — a clue to oestrogen and testosterone exposure in the womb — researchers found that higher prenatal estrogen was linked to larger head size in newborn boys. Tue, 10 Feb 2026 09:42:37 EST https://www.sciencedaily.com/releases/2026/02/260210040559.htm https://www.sciencedaily.com/releases/2026/02/260209064254.htm Scientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new tissue. These helper cells lead the way, allowing cancer to spread faster and resist chemotherapy. The findings uncover a critical weakness that future treatments may target. Mon, 09 Feb 2026 06:51:03 EST https://www.sciencedaily.com/releases/2026/02/260209064254.htm